Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;12(2):e2483.
doi: 10.1002/brb3.2483. Epub 2022 Jan 18.

Rapid cycling bipolar disorder: Literature review on pharmacological treatment illustrated by a case report on ketamine

Alexis Bourla  1   2   3 , Florian Ferreri  1   2 , Thomas Baudry  1 , Vincent Panizzi  1 , Vladimir Adrien  1   2 , Stéphane Mouchabac  1   2
Affiliations
Review

Rapid cycling bipolar disorder: Literature review on pharmacological treatment illustrated by a case report on ketamine

Alexis Bourla et al. Brain Behav. 2022 Feb.

Abstract

Introduction: Rapid cycling bipolar disorder (RCBD) is defined as four or more affective episodes (depression, mania or hypomania) within 1 year. RCBD has a high point of prevalence (from 10% to 20% among clinical bipolar samples) and is associated with greater severity, longer illness duration, worse global functioning and higher suicidal risk, but there is no consensus on treatment option. The use of several pharmacological agents has been reported (levothyroxine, antipsychotics, antidepressants and mood stabilizers).

Objective: The main objective of this review was to propose a critical review of the literature and to rank the pharmacological agent using a level of evidence (LEO) adapted from the Center for Evidence-Based Medicine, and to illustrate it with a case report on off-label intravenous ketamine.

Method: We conducted a review using the MeSH terms and keywords (bipolar [Title/Abstract]) AND (rapid [Title/Abstract]) AND (cycling [Title/Abstract]) AND (treatment [Title/Abstract]). Alexis Bourla and Stéphane Mouchabac screened 638 documents identified through literature search in Medline (PubMed) or by bibliographic references and 164 abstracts were then analyzed. Nonpharmacological treatments were excluded.

Result: Seventy articles were included in the review and divided into six categories: mood stabilizers, antipsychotics, hormonal treatments, ketamine and other pharmacological treatments.

Discussion: Our review highlights the heterogeneity of the pharmacological treatment of RCBD and no clear consensus can emerge.

Keywords: ketamine; pharmacological treatment; rapid cycling bipolar disorder; review.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
PRISMA diagram
See this image and copyright information in PMC

References

    1. Afflelou, S. , Auriacombe, M. , Cazenave, M. , Chartres, J. P. , & Tignol, J. (1997). Utilisation de lévothyroxine à haute dose dans le traitement des troubles bipolaires à cycles rapides. Revue de la littérature et premières applications thérapeutiques à propos de 6 cas [Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Review of the literature and initial therapeutic application apropos of 6 cases]. Encephale, 23(3), 209–217. - PubMed
    1. Amann, B. L. , Mergl, R. , Vieta, E. , Born, C. , Hermisson, I. , Seemueller, F. , Dittmann, S. , & Grunze, H. (2007). A 2‐year, open‐label pilot study of adjunctive chromium in patients with treatment‐resistant rapid‐cycling bipolar disorder. Journal of Clinical Psychopharmacology, 27(1), 104–106. 10.1097/JCP.0b013e31802e744b - DOI - PubMed
    1. Amsterdam, J. D. , Luo, L. , & Shults, J. (2013). Efficacy and mood conversion rate during long‐term fluoxetine v. lithium monotherapy in rapid‐ and non‐rapid‐cycling bipolar II disorder. British Journal of Psychiatry, 202(4), 301–306. 10.1192/bjp.bp.111.104711 - DOI - PMC - PubMed
    1. Baldessarini, R. J. , Hennen, J. , Wilson, M. , Calabrese, J. , Chengappa, R. , Keck P. E. Jr, McElroy, S. L. , Sachs, G. , Vieta, E. , Welge, J. A. , Yatham, L. N. , Zarate C. A. Jr, Baker, R. W. , & Tohen, M. (2003). Olanzapine versus placebo in acute mania: Treatment responses in subgroups. Journal of Clinical Psychopharmacology, 23, 370–376 10.1097/01.jcp.0000085410.08426.9a - DOI - PubMed
    1. Bastiampillai, T. J. , Reid, C. E. , & Dhillon, R. (2010). The long‐term effectiveness of clozapine and lamotrigine in a patient with treatment‐resistant rapid‐cycling bipolar disorder. Journal of Psychopharmacology, 24(12), 1834–1836. 10.1177/0269881109358202 - DOI - PubMed

MeSH terms